12/05/2024
3:24 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:00 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
6:07 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
6:09 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:06 PM | Fennec Pharmaceuticals (Subject)
RALLIS CHRIS A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
4:02 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:13 PM | Fennec Pharmaceuticals (Issuer)
Sayad Pierre Sargis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/13/2024
4:14 PM | Evans Terry L (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:15 PM | Cioffi Christiana Marie (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
6:38 PM | DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024
3:46 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
4:30 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:30 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
6:00 AM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
4:14 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:11 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:13 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
4:02 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
5:33 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
5:48 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
4:30 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4/A | |
08/26/2024
4:51 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
5:59 PM | Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:00 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:00 PM | Brughera Marco Maria (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:01 PM | Cook Jodi A (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:02 PM | Fennec Pharmaceuticals (Issuer)
Islam Khalid (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
5:56 PM | Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/13/2024
4:10 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
3:30 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:21 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
4:55 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:42 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:43 PM | DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
| Form SC 13G | |
06/03/2024
5:21 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:12 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:05 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:05 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:05 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
4:24 PM | Fennec Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
3:42 PM | Fennec Pharmaceuticals (Filer)
| Form DEF 14A | |
We recommended Palantir in 2021, now we’re recommending this... (Ad) My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol |
05/02/2024
3:59 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2024
3:15 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4/A | |
04/22/2024
6:34 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
3:21 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/18/2024
8:43 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
3:24 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:23 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
5:00 PM | Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:15 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024
5:15 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:28 PM | Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
3:19 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
3:46 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
4:37 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
3:55 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:00 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:14 PM | Fennec Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
3:22 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:24 PM | Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
RALLIS CHRIS A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
3:43 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
6:31 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:05 PM | Fennec Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
2:53 PM | Fennec Pharmaceuticals (Filer)
| Form 424B7 | |
01/05/2024
4:24 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:45 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
3:42 PM | Andrade Robert (Reporting)
Fennec Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023
3:30 PM | Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
2:51 PM | Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free FENC Stock Alerts